ClinicalTrials.gov
ClinicalTrials.gov Menu

Skin Care Behaviors Among Melanoma Survivors and Their Families

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02457065
Recruitment Status : Unknown
Verified April 2015 by Dartmouth-Hitchcock Medical Center.
Recruitment status was:  Recruiting
First Posted : May 29, 2015
Last Update Posted : May 29, 2015
Sponsor:
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

Brief Summary:

A patient's sun-related behavior greatly influences the likelihood of that patient developing melanoma, the most dangerous form of skin cancer. Prior research shows current education strategies on inducing preventative behaviors such as wearing sun-protection clothing and wearing sunscreen are inadequate at effectively changing behavior when used in isolation -- patients are aware of the dangers of not engaging in these preventative measures but forgo them nonetheless.

We are investigating methods to positively influence sun protection behaviors among melanoma survivors and their families. The first objective is to compare patient and familial sun exposure and cancer screening activity before and after patients' diagnosis with primary melanoma. The second objective is to note if hanging a "Melanoma Survivor" plaque in a melanoma survivor's bathroom will significantly affect the survivor's and broader family's sun exposure and cancer screening activity.

Our sample of patients consists of survivors of primary cutaneous melanoma less than 4.0 mm in depth who come through the Dermatology Clinic at Dartmouth-Hitchcock Medical Center and voluntarily choose to participate in the study after being informed of the nature of the research. These patients complete a confidential survey assessing a change in sun exposure related activities immediately after their diagnosis. After they fill out the survey, we will ask them if they could nominate a family member to whom we will explain the purpose of our research and confidentially ask an additional set of questions to evaluate the broader impact of a melanoma diagnosis. From our original sample, we will randomly choose a few families who would display the survivor plaque in their primary bathroom. After six-twelve months, during the patient's follow up visit, will ask again both groups of patients and family members to fill out another survey to assess sun exposure related activity.

On the surveys, no names are recorded. Everything is anonymous.


Condition or disease Intervention/treatment Phase
Melanoma Behavioral: Sun protection behaviors Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Skin Care Behaviors Among Melanoma Survivors and Their Families
Study Start Date : March 2015
Estimated Primary Completion Date : January 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Melanoma

Arm Intervention/treatment
Experimental: Receive Plaque
Treatment
Behavioral: Sun protection behaviors
We give the patients a small 3.5 by 2 inch wooden plaque that celebrates their survival of melanoma and reminds them to engage in skin-protective behaviors
Other Name: Melanoma survivor plaque in bathroom

No Intervention: Do Not Receive Plaque
Control



Primary Outcome Measures :
  1. Improved sun-protective behavior survey [ Time Frame: 6-12 months between time of completion of first survey and second survey ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patient has melanoma diagnosis within past 10 years less than 4mm in depth

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02457065


Contacts
Contact: Jonathan A Busam, undergrad. 862-579-0726 Jonathan.A.Busam@hitchcock.org

Locations
United States, New Hampshire
Dartmouth-Hitchcock Medical Center (Heater Road) Recruiting
Lebanon, New Hampshire, United States, 03766
Contact: Pamela Gangar, MD    603-653-9500    pamela.gangar@hitchcock.org   
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Investigators
Principal Investigator: Michael S Chapman, MD Dartmouth-Hitchcock Medical Center

Responsible Party: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT02457065     History of Changes
Other Study ID Numbers: 00028495
First Posted: May 29, 2015    Key Record Dates
Last Update Posted: May 29, 2015
Last Verified: April 2015

Keywords provided by Dartmouth-Hitchcock Medical Center:
survivors
family

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas